Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Travecta Therapeutics Appoints Charles S. Ryan as President and Chief Executive Officer 2021-06-09 21:00
Hummingbird Bioscience and Novogene enter into strategic partnership to expand precision medicine testing for individuals with NRG1-fusion driven cancers in China 2021-06-09 17:00
Travecta Therapeutics Appoints Charles S. Ryan as President and Chief Executive Officer 2021-06-09 13:38
Antengene's Partner Karyopharm Therapeutics Announces Updated Data of Eltanexor in Patients with Hypomethylating Agent Refractory MDS 2021-06-09 08:00
Innoforce Pharmaceuticals to Participate in BIO International Digital Convention 2021-06-08 19:00
TargEDys announces the publication of the first double-blind, randomized, placebo-controlled clinical trial showing Hafnia alvei's efficacy at an unprecedented level in weight loss and satiety 2021-06-08 16:53
Cytiva opens experience and learning lab in Singapore 2021-06-08 10:00
Innovent Biologics and IASO Biotherapeutics to Present Updated Data from its Anti-BCMA CAR-T Therapy in Relapsed/Refractory Multiple Myeloma at European Hematology Association (EHA) Congress 2021-06-08 08:00
Live from ASCO 2021 | Ascentage Pharma Presents Updated Results of MDM2-p53 Inhibitor Alrizomadlin (APG-115) Demonstrating an ORR of 24.1% Including Complete Response in Combination with Pembrolizumab in Patients with Advanced Melanoma Resistant or Refractory to Prior Immuno-Oncologic Drugs 2021-06-08 07:21
RedHill Biopharma Completes Enrollment of Oral Opaganib Phase 2/3 COVID-19 Study 2021-06-07 19:00
OriginCell Therapeutics Presents Positive Results of GPC3 CAR-T in HCC Trial at the 2021 ASCO Annual Meeting 2021-06-07 10:00
Ascletis Received China IND Approval of Its FXR Agonist ASC42 for Chronic Hepatitis B Indication 2021-06-07 08:30
Arctic Vision Announces Exclusive Licensing Agreement with Olympic Ophthalmics for iTEAR®100 for the Treatment of Dry Eye Disease in Greater China, South Korea and ASEAN countries 2021-06-07 08:00
Innovent and HUTCHMED Release Phase 1b preliminary Results of TYVYT (Sintilimab Injection) plus Fruquintinib as a Third Line Treatment for Advanced Colorectal Cancer at ASCO Annual Meeting 2021 2021-06-07 08:00
Innovent and AnHeart Release Preliminary Results from the Phase II TRUST Trial of Taletrectinib in ROS1 Fusion Positive NSCLC at the ASCO 2021 Annual Meeting 2021-06-07 08:00
Innovent Releases the Phase Ia/Ib Dose-Escalation Trial Results of IBI110 (anti-LAG-3) in Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021 2021-06-07 08:00
Innovent Releases Phase 1 Results of Pemigatinib in Chinese Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021 2021-06-07 08:00
Singapore/ US based TurtleTree ready to commercialize Human Lactoferrin as first major product 2021-06-05 01:32
DiNovA's Israel Incubator officially opens its office in Caesarea 2021-06-04 14:00
Elekta Nomination Committee's proposed Board of Directors for the 2021 Annual General Meeting 2021-06-04 13:56
1 239 240 241 242 243 451